The global invertase market size was worth around USD 61.1 million in 2022 and is predicted to grow to around USD 93.7 million by 2030 with a compound annual growth rate (CAGR) of roughly 5.5% between 2023 and 2030.
The study examines the forces driving and restraining the worldwide invertase market, as well as the impact these forces are expected to have on demand during the forecast period. The paper also investigates new openings in the invertase market.
Click Here to access The Full market Report : https://www.zionmarketresearch.com/report/invertase-market-size
The Invertase Industry, in Brief
Hydrolysis of sucrose (table sugar) into glucose and fructose is catalysed by the enzyme invertase. Glycosidases are a class of enzymes responsible for digesting a wide variety of carbohydrates, including those with multiple sugar molecules. One glucose molecule and one fructose molecule are joined together to form a molecule of sucrose, a disaccharide. By hydrolyzing the glycosidic link between sucrose’s glucose and fructose, invertase makes it possible for the sugar to be broken down into its component parts. The enzyme’s name, invertase, comes from the term “inversion,” which describes what it does. Invertase is an important enzyme present in a wide variety of species, including plants, fungus, and even some bacteria. It is found in high concentrations in yeast and finds widespread application in the food sector, where it is used to make inverted sugar (which differs in characteristics from conventional sucrose). Confections, baked foods, and drinks often feature invert sugar as a sweetener. Invertase has useful functions in both industrial and biological contexts. In plants, invertase plays a role in the metabolism of sucrose, facilitating the movement of this sugar throughout the plant where it can be used for energy production or stored. Additionally, invertase has a role in the ripening of fruits and the germination of seeds.
Major Takeaways
• Our research analyst has revealed that the worldwide invertase market is expected to expand at a CAGR of roughly 5.5% between the years 2023 and 2030.
• In 2022, the worldwide invertase market was estimated at roughly USD 61.1 mln, and by 2030, that figure is expected to rise to USD 93.7 mln.
• Invertase is also used in the food and pharmaceutical industries, both of which contribute to the growth of the invertase industry.
The expanding food and drink sector is a key factor in the market’s expansion
One of the largest markets for invertase is the food and beverage business. Invertase’s use in the food industry, particularly in the confectionery, bakery, and beverage industries, has been on the rise in response to the rising demand for processed and convenience foods. The growing global food and beverage industry is a major factor in the need for invertase. For instance, the USDA estimates that in 2021 the agricultural, food, and related industries in the United States contributed about $1.264 trillion to GDP, or 5.4% of total GDP. $164.7 billion, or roughly 0.7% of GDP, came from agricultural production in the United States. Since agriculturally linked companies rely on agricultural inputs to deliver value to the economy, agriculture’s total contribution to GDP is greater than 0.7%.
Market expansion is constrained by strict regulatory regulations
There are rules and regulations regarding the use of invertase in foods and drinks. Limitations on enzyme use are common, and producers are often asked to demonstrate the product’s safety and effectiveness before receiving clearance to sell. Smaller manufacturers in the invertase market may be held back by the time and money required to comply with these laws and gain the requisite permits.
The pharmaceutical and biotechnology industries are seeing rapid growth, providing a potential business opportunity
Invertase is used for more than only digesting food and drinks. It finds application in drug manufacturing, drug delivery, and biotechnology. Invertase is used in a number of biotech and pharmaceutical processes, such as medication manufacturing and the generation of research sugars, because of its capacity to hydrolyze sucrose into glucose and fructose. Thus, the rising demand for invertase in the pharmaceutical and biotechnology sectors represents a promising potential opportunity for the invertase market in the coming years.
A key obstacle is the general public’s lack of knowledge
Consumers may not be aware of the benefits of invertase, despite its widespread use in many food and beverage products. For the invertase industry to expand, it is essential that consumers learn about invertase and its benefits as a natural enzyme and sugar substitute. Demand for items containing invertase may be hampered by consumers’ lack of understanding of the enzyme and their incorrect assumptions about its purpose.
Get more info : https://www.zionmarketresearch.com/buynow/su/invertase-market-size
The Global Invertase Market is segmented based on product, application and region
Global Invertase Market: Product Segment Analysis
● Plant-based
● Microorganism-based
Global Invertase Market: Application Segment Analysis
● Food & Beverages
● Pharmaceuticals
● Personal Care
● Others
The global invertase market is dominated by players like
● Antozyme Biotech Pvt Ltd
● Novozymes
● Infinita Biotech Private Limited
● Sigma-Aldrich Co. LLC.
● Koninklijke DSM N.V.
● Parchem fine & specialty chemicals
● SternEnzym GmbH & Co. KG
● Kerry Inc.
● Meteoric Exim Private Limited
● MP Biomedicals LLC.
● BIO-CAT and Megazyme Inc.
● Others.
Over the projection period, North America is anticipated to be the market leader
The invertase market is anticipated to be largest in North America. The region’s prosperity is due, in large part, to the robust food and beverage and pharmaceutical industries. For instance, the Economic Research Service of the United States Department of Agriculture projects a double-digit percentage increase in 2022 in the demand for organic products among consumers. There is also a demand for organic fruit because there are about 20,000 natural food outlets in the country. Consumers are willing to pay a premium for exceptional health, despite the fact that healthy, natural, and organic produce is more expensive than conventional things like carbonated soft drinks, snack meals, baked goods, staple foods, and caffeinated beverages. The U.S. economy reports a per capita GDP of $16,359. This is an increase over the previous year’s figure of $2,553.
The Asia-Pacific region is predicted to have the fastest compound annual growth rate (CAGR) over the projection period. The expansion of the pharmaceutical industry in the region is largely responsible for this. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) and the Asia-Pacific Trade and Investment Trends 2022/2023, the pharmaceutical industry attracted the highest amount of FDI ($32 billion) between 2008 and 2021, significantly more than investments in the medical devices ($20 billion), the biotechnology ($17 billion), and the healthcare ($10.8 billion) subsectors.
Get Customization Report : https://www.zionmarketresearch.com/custom/7272
About Us :
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.
Be First to Comment